Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.48B | 30.88B | 31.93B | 30.39B | 29.31B | 26.03B | Gross Profit |
4.31B | 5.76B | 6.10B | 5.18B | 5.06B | 4.53B | EBIT |
17.96M | 1.25B | 1.71B | 1.54B | 1.19B | 1.16B | EBITDA |
124.51M | 1.41B | 1.84B | 1.64B | 1.25B | 1.21B | Net Income Common Stockholders |
-353.00M | 497.35M | 904.57M | 845.48M | 630.07M | 574.73M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.14B | 978.25M | 1.42B | 2.53B | 2.04B | 1.30B | Total Assets |
48.15B | 45.42B | 36.59B | 28.96B | 29.24B | 28.12B | Total Debt |
35.36B | 30.70B | 22.39B | 15.27B | 16.50B | 17.43B | Net Debt |
34.22B | 29.72B | 20.97B | 12.74B | 14.46B | 16.13B | Total Liabilities |
39.67B | 35.16B | 26.65B | 19.88B | 20.89B | 20.96B | Stockholders Equity |
8.47B | 10.26B | 9.94B | 9.09B | 8.35B | 7.16B |
Cash Flow | Free Cash Flow | ||||
0.00 | -8.60B | -8.09B | 1.87B | 1.11B | -2.95B | Operating Cash Flow |
0.00 | -7.61B | -6.85B | 2.66B | 2.36B | -2.35B | Investing Cash Flow |
0.00 | -969.22M | -1.25B | -789.67M | -1.25B | -606.22M | Financing Cash Flow |
0.00 | 8.14B | 6.98B | -1.38B | -370.72M | 2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥5.79B | 5.63 | 2.57% | 10.18% | 23.95% | ||
64 Neutral | ¥4.42B | 8.80 | 3.06% | -3.26% | -45.14% | ||
61 Neutral | $2.83B | 10.72 | 0.40% | 6.10% | 5.80% | -21.26% | |
61 Neutral | ¥2.88B | 10.26 | 3.64% | 9.75% | 22.99% | ||
53 Neutral | ¥3.74B | ― | ― | 8.81% | -174.00% | ||
51 Neutral | ¥3.93B | ― | 3.03% | 171.68% | -4626.45% | ||
38 Underperform | ¥3.07B | ― | ― | -36.15% | -153.50% |